Esther Rajavelu - 06 Nov 2023 Form 3 Insider Report for Spero Therapeutics, Inc. (SPRO)

Role: Chief Financial Officer and Chief Business Officer Exhibit 24.1 - Power of Attorney
Signature: /s/ Tamara Joseph, Attorney-in-Fact for Esther Rajavelu
Issuer symbol: SPRO
Transactions as of: 06 Nov 2023
Net transactions value: $0
Form type: 3
Filing time: 15 Nov 2023, 16:15:04 UTC
Previous filing: 13 Feb 2023
Next filing: 15 Nov 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Chief Financial Officer and Chief Business Officer Exhibit 24.1 - Power of Attorney